Almac has plans for a major expansion at its Craigavon headquarters and has acquired a 5.4-acre site for the first phase of development. The expansion plans were prompted by increased demand for development and manufacturing services to pharmaceutical and biotech companies at its Craigavon site. The expansion could potentially create more than 500 jobs during the next five years.

The initial phase includes the construction of a large three-storey office unit to accommodate 220 existing staff and expected recruits. Additionally, plans are under way for a new research facility, as well as a new distribution unit to expand existing capacity.

Group chairman Sir Allen McClay, said, “This is an exciting time for Almac. Since our foundation in 2001 we have grown at record levels, and we expect this trend to continue over the coming years. With our rapid rate of growth it was important to put proper plans in place and provide the necessary room for Almac to expand.”